Your session is about to expire
← Back to Search
Ure-Na for Kidney Stones (Ure-Na Trial)
Ure-Na Trial Summary
This trial is testing whether taking the drug Ure-Na can help to prevent kidney stones from recurring.
- Kidney Stones
Ure-Na Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowUre-Na Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Ure-Na Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this a clinical trial that is only testing elderly individuals?
"The age parameters for this particular trial are 18-60, with 173 similar studies for those under 18 and 1026 for senior citizens."
Are patients currently being sought for this experiment?
"No, this particular trial is not currently recruiting patients. However, it is important to note that there are over a thousand other trials with open enrollment periods."
Could you please tell me about any potential side effects of Ure-Na?
"While there is some evidence to support the safety of Ure-Na, as this is only a Phase 2 trial, Power rates it at a 2."
Would I be a good fit for this particular medical study?
"This trial is looking for 20 participants with kidney stones aged 18 and 60 who meet the following criteria: High risk for recurrence (1 or more of) Bilateral or complex stones, Recurrent stones, Family history (1st degree relative), Non-calcium stones, Solitary kidney or anatomical abnormality, Nephrocalcinosis, Systemic disease with risk of stones (tubular acidosis, cystinuria, etc.), Diuresis < 1.8 L/24 hours despite recommendations from physicians and/or nutritionist at the kidney stone clinic (as documented in the previous 6 months)."
Share this study with friends
Copy Link
Messenger